NCT00898313Recruiting
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Molecular Predictors of Lung Cancer Behavior
Source: ClinicalTrials.gov · Last updated 27 Apr 2026
Brief summary (registry, in English)
RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 9 May 2009
- Start date
- 1 Dec 2003
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Diseases
- Lung cancer
- NCT number
- NCT00898313
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 1 Dec 2003 to the primary completion date, 31 Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to provide informed consent
- Minors
- Pregnant women
Who the study is looking for
- -All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt-Ingram Cancer Center Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
| Veterans Affairs Medical Center - Nashville Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.